Sydney, Australia – October 28, 2015 | Atomo Diagnostics is delighted to announce that the company received the ‘Innovation in Export’ Award at the 2015 Premier’s NSW Export Awards, hosted by the Export Council of Australia.
The award recognises a NSW company that has made innovation an integral part of their exporting process. Atomo currently exports its rapid test products AtomoRapid™ HIV and AtomoRapid™ Malaria to Africa, where the company works with both private sector clients as well as leading NGO’s and public health agencies to ensure that its products can be used in resource limited settings where these diseases have the highest burden.
Atomo also exports its award winning AtomoRapid™ technology to Europe where it is utilised by other diagnostic company’s looking to upgrade their product offerings and provide solutions that deliver improved usability, safety and convenience.
“This achievement for a young company is testament to the hard work our team has put in to build a world-class company commercialising innovative and disruptive diagnostic technology globally,” says John Kelly, CEO of Atomo Diagnostics.
John Kelly said after receiving the award, “Given the types of products we develop and the relatively small size of the Australian market, it is imperative for us to be export focused. Having our design and development and corporate activities located within Sydney, NSW allows us to attract top talent from around the globe and use this as a base to support our innovative global export strategy targeting both global health and developed healthcare markets. Without the support of the Export Council of Australia, this would not be possible.”
About Atomo Diagnostics www.atomodiagnostics.com
Atomo Diagnostics is an award-winning Australian based healthcare company that develops and commercialises next generation solutions addressing unmet user needs in the diagnostic industry.
+61 2 9099 4750